EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

A multicenter evaluation of the QIAstat-Dx meningitis-encephalitis syndromic test kit as compared to the conventional diagnostic microbiology workflow

Stefan A Boers, Robin van Houdt, Nina M van Sorge, Jelle Groot, Yvette van Aarle, Mario J A W M van Bussel, Louise F E Smit, Els Wessels, Eric C J Claas

European Journal of Clinical Microbiology & Infectious Diseases · 2024-03 · 43 (3) · 511-516

DOI: 10.1007/s10096-024-04751-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 11.01.2024. Verfasst von Stefan A Boers und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dept. Medical Microbiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. s.a.boers@lumc.nl. Hauptthemen laut MEDLINE: Meningitis, Encephalitis, Meningitis, Bacterial, Infectious Encephalitis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Rapid diagnosis and treatment of infectious meningitis and encephalitis (ME) is critical to minimize morbidity and mortality. Recently, Qiagen introduced the CE-IVD QIAstat-Dx ME panel (QS-ME) for syndromic diagnostic testing of meningitis and encephalitis. Some data on the performance of the QS-ME in comparison to the BioFire FilmArray ME panel are available. In this study, the performance of the QS-ME is compared to the current diagnostic workflow in two academic medical centers in the Netherlands.

Methods

A total of 110 cerebrospinal fluid samples were retrospectively tested with the QS-ME. The results obtained were compared to the results of laboratory-developed real-time PCR assays (LDTs), IS-pro, bacterial culture, and cryptococcal antigen (CrAg) testing. In addition, the accuracy of the QS-ME was also investigated using an external quality assessment (EQA) panel consisting of ten samples.

Results

Four of the 110 samples tested failed to produce a valid QS-ME result. In the remaining 106 samples, the QS-ME detected 53/53 viral targets, 38/40 bacterial targets, and 7/13 Cryptococcus neoformans targets. The discrepant bacterial results consisted of two samples that were previously tested positive for Listeria monocytogenes (C T 35.8) and Streptococcus pneumoniae (C T 40), respectively. The QS-ME detected one additional result, consisting of a varicella-zoster virus signal (C T 35.9), in a sample in which both techniques detected Streptococcus pyogenes . Finally, 100% concordance was achieved in testing a blinded bacterial ME EQA panel.

Conclusion

The QS-ME is a relevant addition to the syndromic testing landscape to assist in diagnosing infectious ME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningitisEncephalitisMeningitis, BacterialInfectious EncephalitisCryptococcus neoformansHumansRetrospective StudiesWorkflowMultiplex Polymerase Chain ReactionBacteria

Stichwörter der Autor:innen

Central nervous system (CNS) infectionsEncephalitisMeningitisQIAstat-DxSyndromic testing

Autor:innen und Institutionen

  • Dept. Medical Microbiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. s.a.boers@lumc.nl.
  • Dept. Medical Microbiology and Infection prevention, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam UMC location AMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Dept. Medical Microbiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.

Zitieren

APA

Boers, S. A., van Houdt, R., van Sorge, N. M., Groot, J., van Aarle, Y., van Bussel, M. J. A. W. M., Smit, L. F. E., Wessels, E., & Claas, E. C. J. (2024). A multicenter evaluation of the QIAstat-Dx meningitis-encephalitis syndromic test kit as compared to the conventional diagnostic microbiology workflow. European Journal of Clinical Microbiology & Infectious Diseases, 43(3), 511-516. https://doi.org/10.1007/s10096-024-04751-9

Vancouver

Boers SA, van Houdt R, van Sorge NM, Groot J, van Aarle Y, van Bussel MJAWM, et al. A multicenter evaluation of the QIAstat-Dx meningitis-encephalitis syndromic test kit as compared to the conventional diagnostic microbiology workflow. European Journal of Clinical Microbiology & Infectious Diseases. 2024;43(3):511-516. doi:10.1007/s10096-024-04751-9

BibTeX
@article{Boers2024,
  author = {Boers, Stefan A and van Houdt, Robin and van Sorge, Nina M and Groot, Jelle and van Aarle, Yvette and van Bussel, Mario J A W M and Smit, Louise F E and Wessels, Els and Claas, Eric C J},
  title = {A multicenter evaluation of the QIAstat-Dx meningitis-encephalitis syndromic test kit as compared to the conventional diagnostic microbiology workflow},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  volume = {43},
  number = {3},
  pages = {511--516},
  doi = {10.1007/s10096-024-04751-9}
}
Kostenlos starten →